1. Signaling Pathways
  2. MAPK/ERK Pathway
  3. MNK

MNK 

Mitogen activated protein kinase interacting kinase; MAP kinase interacting kinase; MAPK interacting kinase

丝裂原活化蛋白激酶相互作用激酶 1 和 2 (MNK1 和 MNK2) 磷酸化丝氨酸 209 上的致癌基因 eIF4E。据报道,这种磷酸化是其致癌活性所必需的。真核起始因子 4E (eIF4E) 是翻译机制的关键组成部分,也是细胞生长和增殖的重要调节剂。eIF4E 的活性被认为是通过与抑制性结合蛋白 (4E-BP) 的相互作用以及丝裂原活化蛋白 (MAP) 激酶相互作用激酶 (MNK) 在丝裂原和细胞应激反应下对 Ser209 的磷酸化来调节的。

Mitogen-activated protein kinase-interacting kinases 1 and 2 (MNK1 and MNK2) phosphorylate the oncogene eIF4E on serine 209. This phosphorylation has been reported to be required for its oncogenic activity. Eukaryotic initiation factor 4E (eIF4E) is a key component of the translational machinery and an important modulator of cell growth and proliferation. The activity of eIF4E is thought to be regulated by interaction with inhibitory binding proteins (4E-BPs) and phosphorylation by mitogen-activated protein (MAP) kinase-interacting kinase (MNK) on Ser209 in response to mitogens and cellular stress.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-162260
    MNK-IN-4 Inhibitor
    MNK-IN-4 (compound D25) 是一种有效的选择性 MNK 抑制剂,用于治疗脓毒症相关的急性脾损伤。
    MNK-IN-4

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.